Translational Development Acquisition Corp.
For the period ended Dec 31, 2024. Filed Mar 31, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Mar 31, 2025
TDAC$10.87+0.0%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Statements of Operations
| | | | | | | |
|---|---|---|---|---|---|---|
| · · For the Year Ended December 31, | ||||||
| · 2024 · 2023 | ||||||
| Operating and formation costs | | $196,358 | | $485,550 | ||
| Loss from operations | | (196,358) | | (485,550) | ||
| | | | | | | |
| Other income: | | | ||||
| Dividends earned on marketable securities held in Trust Account | | 125,346 | | — | ||
| Total other income | | 125,346 | | — | ||
| | | | | | | |
| Net loss | | $(71,012) | | $(485,550) | ||
| | | | | | | |
| Weighted average shares outstanding of Class A ordinary shares – basic | | 330,822 | | — | ||
| Basic net loss per ordinary share, Class A ordinary shares | | $(0.02) | | $— | ||
| Weighted average shares outstanding of Class A ordinary shares - diluted | | 330,822 | | — | ||
| Diluted net loss per ordinary share, Class A ordinary shares | | $(0.01) | | $— | ||
| Weighted average shares outstanding of Class B ordinary shares – basic | | 4,061,651 | | 4,050,000 | ||
| Basic net loss per ordinary share, Class B ordinary shares | | $(0.02) | | $(0.12) | ||
| Weighted average shares outstanding of Class B ordinary shares – diluted | | 4,657,500 | | 4,050,000 | ||
| Diluted net loss per ordinary share, Class B ordinary shares | | $(0.01) | | $(0.12) | ||
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.